Especially the relatively high inflammatory effector cells, such as NK cells and CD8+ T cells are, in humans, generally associated with longer survival and less aggressive tumor growth [51], which needs to be considered when using this tumor model for immunological studies on PDAC progression. The gene discussed is CD8A; the disease is neoplasm.